ID   IGHE_RAT                Reviewed;         429 AA.
AC   P01855;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   21-JUL-1986, sequence version 1.
DT   02-OCT-2024, entry version 120.
DE   RecName: Full=Immunoglobulin heavy constant epsilon;
DE   AltName: Full=Ig epsilon chain C region;
GN   Name=IGHE;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (IMMUNOCYTOMA IR2).
RC   STRAIN=LOU/C/WSL;
RX   PubMed=6292865; DOI=10.1093/nar/10.19.6041;
RA   Hellman L., Pettersson U., Engstroem A., Karlsson T., Bennich H.;
RT   "Structure and evolution of the heavy chain from rat immunoglobulin E.";
RL   Nucleic Acids Res. 10:6041-6049(1982).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 168-342 (MYELOMA IR162).
RX   PubMed=6820340; DOI=10.1089/dna.1982.1.335;
RA   Kindsvogel W.R., Reddy E.P., Moore J.M., Faust C.H. Jr.;
RT   "A cloned cDNA probe for rat immunoglobulin epsilon heavy chain:
RT   construction, identification, and DNA sequence.";
RL   DNA 1:335-343(1982).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 205-306.
RX   PubMed=6803238; DOI=10.1073/pnas.79.4.1264;
RA   Hellman L., Pettersson U., Bennich H.;
RT   "Characterization and molecular cloning of the mRNA for the heavy (epsilon)
RT   chain of rat immunoglobulin E.";
RL   Proc. Natl. Acad. Sci. U.S.A. 79:1264-1268(1982).
CC   -!- FUNCTION: Constant region of immunoglobulin heavy chains.
CC       Immunoglobulins, also known as antibodies, are membrane-bound or
CC       secreted glycoproteins produced by B lymphocytes. In the recognition
CC       phase of humoral immunity, the membrane-bound immunoglobulins serve as
CC       receptors which, upon binding of a specific antigen, trigger the clonal
CC       expansion and differentiation of B lymphocytes into immunoglobulins-
CC       secreting plasma cells. Secreted immunoglobulins mediate the effector
CC       phase of humoral immunity, which results in the elimination of bound
CC       antigens. The antigen binding site is formed by the variable domain of
CC       one heavy chain, together with that of its associated light chain.
CC       Thus, each immunoglobulin has two antigen binding sites with remarkable
CC       affinity for a particular antigen. The variable domains are assembled
CC       by a process called V-(D)-J rearrangement and can then be subjected to
CC       somatic hypermutations which, after exposure to antigen and selection,
CC       allow affinity maturation for a particular antigen.
CC       {ECO:0000250|UniProtKB:P01854}.
CC   -!- SUBUNIT: The basic structural unit consists of two identical heavy
CC       chains and two identical light chains; disulfide-linked. N-terminal
CC       variable regions of the heavy and light chains form the antigen binding
CC       sites, whereas the C-terminal constant regions of the heavy chains
CC       interact with immune receptors to mediate effector functions.
CC       {ECO:0000250|UniProtKB:P01854}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250|UniProtKB:P01854}. Cell
CC       membrane {ECO:0000250|UniProtKB:P01854}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA41379.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J00744; AAA41379.1; ALT_INIT; mRNA.
DR   PIR; A93442; EHRT.
DR   AlphaFoldDB; P01855; -.
DR   SMR; P01855; -.
DR   GlyGen; P01855; 1 site, 1 O-linked glycan (1 site).
DR   PaxDb; 10116-ENSRNOP00000006912; -.
DR   AGR; RGD:2880; -.
DR   RGD; 2880; Ighe.
DR   eggNOG; ENOG502R54U; Eukaryota.
DR   InParanoid; P01855; -.
DR   PhylomeDB; P01855; -.
DR   TreeFam; TF334176; -.
DR   PRO; PR:P01855; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0071744; C:IgE B cell receptor complex; ISO:RGD.
DR   GO; GO:0031902; C:late endosome membrane; IBA:GO_Central.
DR   GO; GO:0005765; C:lysosomal membrane; IBA:GO_Central.
DR   GO; GO:0042613; C:MHC class II protein complex; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0023026; F:MHC class II protein complex binding; IBA:GO_Central.
DR   GO; GO:0042605; F:peptide antigen binding; IBA:GO_Central.
DR   GO; GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; IBA:GO_Central.
DR   GO; GO:0030183; P:B cell differentiation; ISO:RGD.
DR   GO; GO:0050853; P:B cell receptor signaling pathway; ISO:RGD.
DR   GO; GO:0002503; P:peptide antigen assembly with MHC class II protein complex; IBA:GO_Central.
DR   GO; GO:0050778; P:positive regulation of immune response; IBA:GO_Central.
DR   GO; GO:0050870; P:positive regulation of T cell activation; IBA:GO_Central.
DR   CDD; cd05768; IgC1_CH3_IgAGD_CH4_IgAEM; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 4.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR050380; Immune_Resp_Modulators.
DR   InterPro; IPR013151; Immunoglobulin_dom.
DR   PANTHER; PTHR23411:SF30; IMMUNOGLOBULIN HEAVY CONSTANT EPSILON; 1.
DR   PANTHER; PTHR23411; TAPASIN; 1.
DR   Pfam; PF07654; C1-set; 3.
DR   Pfam; PF00047; ig; 1.
DR   SMART; SM00407; IGc1; 4.
DR   SUPFAM; SSF48726; Immunoglobulin; 4.
DR   PROSITE; PS50835; IG_LIKE; 4.
DR   PROSITE; PS00290; IG_MHC; 3.
PE   2: Evidence at transcript level;
KW   Cell membrane; Disulfide bond; Immunoglobulin domain; Membrane;
KW   Reference proteome; Repeat; Secreted.
FT   CHAIN           <1..429
FT                   /note="Immunoglobulin heavy constant epsilon"
FT                   /id="PRO_0000153576"
FT   DOMAIN          6..89
FT                   /note="Ig-like 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DOMAIN          103..201
FT                   /note="Ig-like 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DOMAIN          205..305
FT                   /note="Ig-like 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DOMAIN          314..414
FT                   /note="Ig-like 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        26..78
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        125..184
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        230..289
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        334..396
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   CONFLICT        168
FT                   /note="R -> N (in Ref. 2)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        308
FT                   /note="P -> L (in Ref. 2)"
FT                   /evidence="ECO:0000305"
FT   NON_TER         1
SQ   SEQUENCE   429 AA;  48671 MW;  D2970B34EF8A72B0 CRC64;
     VSVKAPSLYP LKPCSSENTA SVTLGCLVKD YFPDPVTVTW YSDSLNTSTM NFPSIGSDLK
     TTTSQMTSWG KSAKNFTCHV THAPSTFVSD LTIRARPVNI TKPTVDLLHS SCDPNAFHST
     IQLYCFVYGH IQNDVSIHWL MDDRKIYETH AQNVLIKEEG KLASTYSRLN ITQQQWMSES
     TFTCKVTSQG ENYWAHTRRC SDDEPRGVIT YLIPPSPLDL YENGTPKLTC LVLDLESEEN
     ITVTWVRERK KSIGSASQRS TKHHNATTSI TSILPVDAKD WIEGEGYQCR VDHPHFPKPI
     VRSITKAPGK RSAPEVYVFL PPEEEEKDKR TLTCLIQNFF PEDISVQWLQ DSKLIPKSQH
     STTTPLKYNG SNQRFFIFSR LEVTKALWTQ TKQFTCRVIH EALREPRKLE RTISKSLGNT
     SLRPSQASM
//
